3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
63
Neoplasms
5
Neoplasm Metastasis
5
Carcinoma, Intraductal, Noninfiltrating
3
Breast Neoplasms, Male
3
Recurrence
2
Ovarian Neoplasms
2
Endometrial Neoplasms
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Tuberous Sclerosis
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunctions, Psychological
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms by Site
1
Multiple Endocrine Neoplasia Type 1
1
Locoregional Recurrence
1
Hyperglycemia
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
HER2-positive Breast Cancer
1
Granulosa cell tumor of the ovary
1
Endometrial Stromal Tumors
1
Endometrial Hyperplasia
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
8
Tamoxifen
6
Standard of Care
4
Practice Guidelines as Topic
4
Radiotherapy
3
Methods
3
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Radiation
2
Educational Status
2
Early Intervention, Educational
2
Counseling
2
ruxolitinib
1
pembrolizumab
1
exemestane
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
abemaciclib
1
Watchful Waiting
1
Telemedicine
1
Taxes
1
Tablets
1
Surveys and Questionnaires
1
Starch
1
Reverse Transcriptase Polymerase Chain Reaction
1
Ranitidine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Carcinoma In Situ
×
exemestane
×
1 year
×
Clear all
NCT06671912
2026-06-02
LoTam
Alliance for Clinical Trials in Oncology
Phase 3
Suspended
1,156 enrolled